135 related articles for article (PubMed ID: 9326429)
1. Therapeutic use of an extemporaneously prepared oral suspension of tacrolimus in pediatric patients.
McGhee B; McCombs JR; Boyle G; Webber SA; Reyes JR
Transplantation; 1997 Sep; 64(6):941-2. PubMed ID: 9326429
[No Abstract] [Full Text] [Related]
2. Campath-1H in intestinal and multivisceral transplantation: preliminary data.
Tzakis AG; Kato T; Nishida S; Levi D; Madariaga J; De Faria W; Nery J; Neff G; Kirk AD; Ruiz P
Transplant Proc; 2002 May; 34(3):937. PubMed ID: 12034248
[No Abstract] [Full Text] [Related]
3. Mycophenolate mofetil as primary and rescue therapy in intestinal transplantation.
Tzakis AG; Weppler D; Khan MF; Koutouby R; Romero R; Viciana AL; Raskin J; Nery JR; Thompson J
Transplant Proc; 1998 Sep; 30(6):2677-9. PubMed ID: 9745545
[No Abstract] [Full Text] [Related]
4. Early pharmacokinetic profiles of enteral tacrolimus after multivisceral transplantation.
Hansen LJ; Puzycz P; Gooi HC; Lodge P; Pollard S
Transplant Proc; 1997 May; 29(3):1861. PubMed ID: 9142303
[No Abstract] [Full Text] [Related]
5. Oral administration of FK 506 in a swine model of liver-small bowel allotransplantation.
Reggiani P; Gatti S; Rossi G; Orsenigo R; Maggi U; Leoni L; Ceccherelli F; Colledan M; Gridelli B; Piazzini-Albani A; Galmarini M; Andreani P; Bardella MT; Langer M; Doglia M; Fassati LR; Galmarini D
Transplant Proc; 1996 Oct; 28(5):2587-8. PubMed ID: 8907965
[No Abstract] [Full Text] [Related]
6. Efficacy and pharmacokinetics of tacrolimus oral suspension in pediatric liver transplant recipients.
Reding R; Sokal E; Paul K; Janssen M; Evrard V; Wilmotte L; Chardot C; Otte JB; Wallemacq P
Pediatr Transplant; 2002 Apr; 6(2):124-6. PubMed ID: 12000467
[TBL] [Abstract][Full Text] [Related]
7. The long-term efficacy of multivisceral transplantation.
Madariaga JR; Reyes J; Mazariegos G; Fung JJ; Starzl TE; Abu-Elmagd K
Transplant Proc; 2000 Sep; 32(6):1219-20. PubMed ID: 10995918
[No Abstract] [Full Text] [Related]
8. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
Wagner K; Webber SA; Kurland G; Boyle GJ; Miller SA; Cipriani L; Griffith BP; Fricker FJ
J Heart Lung Transplant; 1997 Mar; 16(3):275-82. PubMed ID: 9087870
[TBL] [Abstract][Full Text] [Related]
9. Frequency of switch from cyclosporine to FK 506 before and after Neoral use in pediatric liver transplantation.
Gridelli B; Colledan M; Lucianetti A; Ulla L; Riva S; Segalin A; Fassati LR; Torre G
Transplant Proc; 1998 Aug; 30(5):1861-2. PubMed ID: 9723311
[No Abstract] [Full Text] [Related]
10. Tacrolimus and mycophenolate mofetil in pig small bowel transplantation: different protocols and their outcome.
Spada M; Alessiani M; Ferrari P; Iacona I; Abbiati F; Viezzoli A; Regazzi MB; Bellinzona G; Dionigi P; Zonta A
Transplant Proc; 1997 May; 29(3):1819-20. PubMed ID: 9142286
[No Abstract] [Full Text] [Related]
11. Two-year experience with FK 506 in pediatric patients.
Tzakis AG; Reyes J; Todo S; Nour B; Shapiro R; Jordan M; McCauley J; Armitage J; Fung JJ; Starzl TE
Transplant Proc; 1993 Feb; 25(1 Pt 1):619-21. PubMed ID: 7679822
[No Abstract] [Full Text] [Related]
12. Small bowel transplantation alone or with the liver in children: changes by using FK506.
Goulet O; Michel JL; Jobert A; Damotte D; Colomb V; Cezard JP; Lacaille F; Faure C; Jan D; Jabri B; Sarnacki S; Brousse N; Peuchmaur M; Aigrain Y; Ricour C; Revillon Y
Transplant Proc; 1998 Jun; 30(4):1569-70. PubMed ID: 9636636
[No Abstract] [Full Text] [Related]
13. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
Melter M; Rodeck B; Kardorff R; Hoyer PF; Maibücher A; Brodehl J
Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224
[No Abstract] [Full Text] [Related]
14. Intestinal transplantation: advances in immunosuppression and surgical techniques.
Tzakis AG; Tryphonopoulos P; Kato T; Nishida S; Levi DM; Nery JR; Madariaga J; De Faria W; Mittal N; Thompson JF; Ruiz P
Transplant Proc; 2003 Aug; 35(5):1925-6. PubMed ID: 12962850
[TBL] [Abstract][Full Text] [Related]
15. Conversion from tacrolimus to microemulsion formulation of cyclosporine in pediatric liver transplantation.
Alberti D; Reding R; Otte JB; Falchetti D; Rigamonti W; Caccia G; Sokal E; de Ville de Goyet J
Transplant Proc; 1998 Aug; 30(5):1858-60. PubMed ID: 9723310
[No Abstract] [Full Text] [Related]
16. Tacrolimus (FK506) proves superior to OKT3 for treating episodes of persistent rejection following intrathoracic transplantation.
Meiser BM; Uberfuhr P; Schulze C; Fuchs A; Mair H; Reichenspurner H; Kreuzer E; Reichart B
Transplant Proc; 1997; 29(1-2):605-6. PubMed ID: 9123150
[No Abstract] [Full Text] [Related]
17. Tolerability of mycophenolate mofetil in organ transplant recipients.
Schweizer RT; Meisterling LD
Transplant Proc; 2001 May; 33(3):2309. PubMed ID: 11377540
[No Abstract] [Full Text] [Related]
18. Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients.
Jain A; Venkataramanan R; Todo S; Abu-Elmagd K; Fung J; Warty V; Tzakis A; Reyes J; Alessiani M; Starzl TE
Transplant Proc; 1992 Jun; 24(3):1181-2. PubMed ID: 1376518
[No Abstract] [Full Text] [Related]
19. The Swedish nationwide experience of converting transplant patients treated with Sandimmun to the new galenic formulation Sandimmun-neoral. The Swedish Sandimmun-Neoral Conversion Group.
Wilczek HE; Berglin E; Blohmé I; Bäckman L; Fehrman I; Källen R; Nyberg G; Säwe J; Wahlberg J
Transplant Proc; 1997; 29(1-2):280-3. PubMed ID: 9122995
[No Abstract] [Full Text] [Related]
20. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.
Lindenfeld J; Miller GG; Shakar SF; Zolty R; Lowes BD; Wolfel EE; Mestroni L; Page RL; Kobashigawa J
Circulation; 2004 Dec; 110(25):3858-65. PubMed ID: 15611389
[No Abstract] [Full Text] [Related]
[Next] [New Search]
